Amikacin EP Impurity B
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

927821-99-6Amikacin EP Impurity B

● In Stock

Catalogue No.:VL6230002
CAS No.:927821-99-6
Mol. Formula:C26H50N6O15
Mol. Weight:686.71 g/mol

Additional information on CAS 927821-99-6

Parent drug

Amikacin

IUPAC Name

4-O-(3-Amino-3-deoxy-α-D-glucopyranosyl)-6-O-(6-amino-6-deoxy-α-D-glucopyranosyl)-1,3-N-bis[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-L-streptamine

Synonyms

N/A

Description

Amikacin EP Impurity B, CAS 927821-99-6, is a structurally defined aminoglycoside-related impurity associated with amikacin, a semi-synthetic 4,6-disubstituted deoxystreptamine antibiotic. With molecular formula C26H50N6O15 and molecular weight 686.71 g/mol, it is characterized by the conserved polyhydroxylated aminocyclitol core and multiple glycosidic functionalities, consistent with a process-related or transformation impurity arising during semisynthesis, hydrolysis, or epimeric rearrangement of the parent drug. Owing to its close structural similarity to amikacin, assignment typically requires LC-MS/MS with high-resolution mass spectrometry and orthogonal ion-exchange or HILIC chromatographic separation, with NMR used when structural elucidation is necessary.

References

Ristuccia AM, Cunha BA. An overview of amikacin. Therapeutic Drug Monitoring. 1985 ;7(1):12-25. DOI: 10.1097/00007691-198503000-00003. PMID: 3887667.http://europepmc.org/article/med/3887667 Wang, Jian, et al. “Separation and Characterization of Unknown Impurities in Amikacin Sulfate by HPLC–MS N.” Chromatographia, vol. 78, no. 15-16, Springer Science+Business Media, May 2015, pp. 1031–39, https://doi.org/10.1007/s10337-015-2909-8 . Accessed 26 Oct. 2023.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url